Molecular epidemiology of macrolide resistance in neonatal bloodstream isolates of group B streptococci

被引:37
作者
Diekema, DJ
Andrews, JI
Huynh, H
Rhomberg, PR
Doktor, SR
Beyer, J
Shortridge, VD
Flamm, RK
Jones, RN
Pfaller, MA
机构
[1] Univ Iowa, Coll Med & Publ Hlth, Dept Internal Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med & Publ Hlth, Dept Pathol, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Med & Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA
[4] Univ Iowa, Coll Med & Publ Hlth, Dept Obstet Gynecol, Iowa City, IA 52242 USA
[5] Jones Grp Jones Microbiol Inst, Iowa City, IA USA
[6] Abbott Labs, Abbott Pk, IL 60064 USA
[7] Tufts Univ, Sch Med, Dept Internal Med, Boston, MA 02111 USA
关键词
D O I
10.1128/JCM.41.6.2659-2661.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Pulsed-field gel electrophoresis (PFGE) was performed on 122 neonatal bloodstream isolates of group B streptococci (GBS) to further examine the relationship between macrollide resistance and serotype V GBS (GBS-V). Over one-third (35%) of macrollide-resistant GBS belonged to a single PFGE subtype of GBS-V, which was also the most common GBS-V subtype noted in previous Centers for Disease Control and Prevention surveillance studies. Erm methylase (ermA and ermB) was the most common resistance mechanism detected, present in 12 of 20 macrolide-resistant GBS.
引用
收藏
页码:2659 / 2661
页数:3
相关论文
共 21 条
  • [1] Group B streptococci causing neonatal bloodstream infection: Antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere
    Andrews, JI
    Diekema, DJ
    Hunter, SK
    Rhomberg, PR
    Pfaller, MA
    Jones, RN
    Doern, GV
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (04) : 859 - 862
  • [2] [Anonymous], 1999, M100S9 NAT COMM CLIN
  • [3] Invasive group B streptococcal disease: The emergence of serotype V
    Blumberg, HM
    Stephens, DS
    Modansky, M
    Erwin, M
    Elliot, J
    Facklam, RR
    Schuchat, A
    Baughman, W
    Farley, MM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (02) : 365 - 373
  • [4] Macrolide and tetracycline resistance and molecular relationships of clinical strains of Streptococcus agalactiae
    Culebras, E
    Rodriguez-Avial, I
    Betriu, C
    Redondo, M
    Picazo, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) : 1574 - 1576
  • [5] Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada
    de Azavedo, JCS
    McGavin, M
    Duncan, C
    Low, DE
    McGeer, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3504 - 3508
  • [6] Antibiotic susceptibility and mechanisms of erythromycin resistance in clinical isolates of Streptococcus agalactiae:: French multicenter study
    De Mouy, D
    Cavallo, JD
    Leclercq, R
    Fabre, R
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (08) : 2400 - 2402
  • [7] Sudden increase in isolation of group B streptococci, serotype V, is not due to emergence of a new pulsed-field gel electrophoresis type
    Elliott, JA
    Farmer, KD
    Facklam, RR
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) : 2115 - 2116
  • [8] Mechanisms of macrolide resistance in clinical group B streptococci isolated in France
    Fitoussi, F
    Loukil, C
    Gros, I
    Clermont, O
    Mariani, P
    Bonacorsi, S
    Le Thomas, I
    Deforche, D
    Bingen, E
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1889 - 1891
  • [9] EMERGENCE OF SEROTYPE-V GROUP-B STREPTOCOCCAL INFECTION AMONG INFANTS AND ADULTS
    HARRISON, LH
    DWYER, DM
    JOHNSON, JA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (02) : 513 - 513
  • [10] Serotype distribution of invasive group B streptococcal isolates in Maryland: Implications for vaccine formulation
    Harrison, LH
    Elliott, JA
    Dwyer, DM
    Libonati, JP
    Ferrieri, P
    Billmann, L
    Schuchat, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (04): : 998 - 1002